Phase 3 trials of a Sinopharm coronavirus vaccine in China have been found to be 79 percent effective, the Chinese pharma giant said on Wednesday. It is however lower than rival jabs developed by Pfizer-BioNTech and Moderna. More than one million people have already been vaccinated with unapproved vaccines in China under its emergency use programme.from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/38J1dFn
Post a Comment